Penumbra Total Long-Term Assets 2014-2024 | PEN
Penumbra total long-term assets from 2014 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
- Penumbra total long-term assets for the quarter ending June 30, 2024 were $0.591B, a 2.3% decline year-over-year.
- Penumbra total long-term assets for 2023 were $0.641B, a 4.18% increase from 2022.
- Penumbra total long-term assets for 2022 were $0.615B, a 9.31% increase from 2021.
- Penumbra total long-term assets for 2021 were $0.563B, a 174.15% increase from 2020.
| Penumbra Annual Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2023 | $641 |
| 2022 | $615 |
| 2021 | $563 |
| 2020 | $205 |
| 2019 | $203 |
| 2018 | $104 |
| 2017 | $94 |
| 2016 | $44 |
| 2015 | $19 |
| 2014 | $6 |
| 2013 | $9 |
| Penumbra Quarterly Total Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-06-30 | $591 |
| 2024-03-31 | $645 |
| 2023-12-31 | $641 |
| 2023-09-30 | $600 |
| 2023-06-30 | $605 |
| 2023-03-31 | $609 |
| 2022-12-31 | $615 |
| 2022-09-30 | $598 |
| 2022-06-30 | $610 |
| 2022-03-31 | $611 |
| 2021-12-31 | $563 |
| 2021-09-30 | $305 |
| 2021-06-30 | $257 |
| 2021-03-31 | $206 |
| 2020-12-31 | $205 |
| 2020-09-30 | $220 |
| 2020-06-30 | $204 |
| 2020-03-31 | $211 |
| 2019-12-31 | $203 |
| 2019-09-30 | $163 |
| 2019-06-30 | $151 |
| 2019-03-31 | $146 |
| 2018-12-31 | $104 |
| 2018-09-30 | $103 |
| 2018-06-30 | $107 |
| 2018-03-31 | $102 |
| 2017-12-31 | $94 |
| 2017-09-30 | $87 |
| 2017-06-30 | $52 |
| 2017-03-31 | $46 |
| 2016-12-31 | $44 |
| 2016-09-30 | $30 |
| 2016-06-30 | $24 |
| 2016-03-31 | $21 |
| 2015-12-31 | $19 |
| 2015-09-30 | $10 |
| 2015-06-30 | |
| 2015-03-31 | |
| 2014-12-31 | |
| 2014-09-30 | |
| 2013-12-31 | $12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.597B | $1.059B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $233.063B | 27.94 |
| Intuitive Surgical (ISRG) | United States | $171.313B | 97.00 |
| Alcon (ALC) | Switzerland | $47.672B | 33.56 |
| IQVIA Holdings (IQV) | United States | $44.239B | 25.07 |
| IDEXX Laboratories (IDXX) | United States | $42.083B | 50.62 |
| Edwards Lifesciences (EW) | United States | $40.680B | 26.07 |
| DexCom (DXCM) | United States | $27.834B | 39.69 |
| STERIS (STE) | Ireland | $23.508B | 27.43 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.781B | 0.00 |
| Waters (WAT) | United States | $19.789B | 29.50 |
| Hologic (HOLX) | United States | $18.981B | 20.64 |
| Sysmex ADR (SSMXY) | Japan | $12.317B | 38.62 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.224B | 13.70 |
| Teleflex (TFX) | United States | $11.380B | 17.69 |
| Globus Medical (GMED) | United States | $9.423B | 26.36 |
| Glaukos (GKOS) | United States | $6.721B | 0.00 |
| Masimo (MASI) | United States | $6.081B | 32.57 |
| TransMedics (TMDX) | United States | $5.203B | 222.80 |
| PROCEPT BioRobotics (PRCT) | United States | $4.309B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.304B | 25.17 |
| Tandem Diabetes Care (TNDM) | United States | $2.791B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.773B | 16.26 |
| Veracyte (VCYT) | United States | $2.593B | 160.76 |
| Inari Medical (NARI) | United States | $2.586B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.562B | 20.88 |
| Nihon Kohden (NHNKY) | Japan | $2.508B | 15.61 |
| RxSight (RXST) | United States | $2.003B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.360B | 6.19 |
| Pulse Biosciences (PLSE) | United States | $1.163B | 0.00 |
| OPKO Health (OPK) | United States | $1.130B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.112B | 19.84 |
| Artivion (AORT) | United States | $1.046B | 96.04 |
| Alphatec Holdings (ATEC) | United States | $0.864B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.728B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.682B | 17.23 |
| SiBone (SIBN) | United States | $0.654B | 0.00 |
| AxoGen (AXGN) | United States | $0.638B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.616B | 0.00 |
| IRadimed (IRMD) | United States | $0.614B | 33.19 |
| Paragon 28 (FNA) | United States | $0.581B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.526B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.341B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.330B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.327B | 9.98 |
| ClearPoint Neuro (CLPT) | United States | $0.322B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.306B | 0.00 |
| Inogen (INGN) | United States | $0.253B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.251B | 0.00 |
| Nevro (NVRO) | United States | $0.217B | 0.00 |
| NeuroPace (NPCE) | United States | $0.199B | 0.00 |
| Accuray (ARAY) | United States | $0.190B | 0.00 |
| CVRx (CVRX) | United States | $0.189B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.179B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.173B | 12.15 |
| Alpha Tau Medical (DRTS) | Israel | $0.162B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.135B | 0.00 |
| 908 Devices (MASS) | United States | $0.128B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.122B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.114B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.099B | 14.81 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.066B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.062B | 0.00 |
| Envoy Medical (COCH) | United States | $0.061B | 0.00 |
| LENSAR (LNSR) | United States | $0.049B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.045B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.038B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.035B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.032B | 0.00 |
| Neuronetics (STIM) | United States | $0.029B | 0.00 |
| Lifeward (LFWD) | United States | $0.028B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.022B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.022B | 0.00 |
| Spectral AI (MDAI) | United States | $0.021B | 0.00 |
| PAVmed (PAVM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.016B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |